Defense Appropriations Act to fund biosensors

Southwestern Pennsylvania will receive more than $24 million in funding for projects, including some to fight bioterror, as part of the Fiscal Year 2010 Defense Appropriations Act recently approved by Congress and signed over the weekend by President Obama.

“These projects will encourage job creation and bolster our nation’s security,” Sen. Bob Casey said in a written statement. “I am pleased the Congress has approved this important funding, which will promote economic growth in Pennsylvania, ensure that our service members have state-of-the-art equipment and projection and strengthen our nation’s defense.”

As part of the funding, ChemImage Corp., based in Pittsburgh, will receive $2 million to develop sensors that can be used to quickly detect chemical, biological, explosive and improvised explosive device threats.

ChemImage, founded in 1994, is a provider of chemical imaging, raman imaging and fluorescence imaging technologies as well as forensics and threat detection for application in the biological and chemical fields.

In the past, ChemImage has collaborated with the Mayo Clinic, the Cleveland Clinic, the Food and Drug Administration and Homeland Security to create advances in bio-medicine, forensic science, pharmaceuticals and threat detection.

Currently, ChemImage holds 91 U.S. issued patents, 12 allowed patents and more than 100 U.S. and foreign patents for technology and methodology advancements.